Global Cancer Biomarkers Market
Overview:
Cancer biomarkers are biological molecules produced by the body or tumor in an individual with cancer. They help in the management of cancer patients by increasing the efficiency of the treatment. Cancer biomarkers include various biochemical components such as nucleic acids, lipids, sugars, proteins, cytogenetic and cytokinetic parameters, small metabolites, and whole tumor cells, which are found in body fluid.
Drivers:
Increasing prevalence of cancer, need for early diagnosis, introduction of better and affordable biomarkers, advancements in cancer biomarkers, and continuous research and development is expected to boost the growth of the global cancer biomarkers market over the forecast period. For instance, according to the data published in March 2018 in Cell Metabolism Journal, a team of Australian researchers found a unique metabolic marker that can help detect a form of lung cancer, known as adenocarcinomas. Cancer biomarkers respond to immunotherapies and offers simple, non-invasive blood test for early diagnosis of lung cancer.
๐๐จ ๐๐๐ญ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐๐๐ญ๐๐ฌ๐ญ ๐๐จ๐ฏ๐ข๐๐๐ ๐๐ฆ๐ฉ๐๐๐ญ ๐๐ง๐๐ฅ๐ฒ๐ฌ๐ข๐ฌ @ https://www.coherentmarketinsights.com/insight/request-sample/175
Moreover, in February 2018, Georgetown-Lombardi Comprehensive Cancer Center identified biomarkers that can use liquid biopsies to predict cancer treatment response and help identify specific subsets of GI cancers to make treatment decisions.
Furthermore, market players are focusing on developing new cancer biomarkers to meet the growing demand for early cancer diagnosis, which in turn is also expected to propel growth of the global cancer biomarkers market. For instance, in 2016, Oxford Cancer Biomarkers Ltd. announced the launch of ColoTox test to predict the risk of toxicity with cancer chemotherapy tests. While, in December 2015, Olink Bioscience announced the launch of Proseek Multiplex Oncology II96x96, a new human protein biomarker panel that targets the cancer research area.
๐๐ฎ๐ฒ ๐๐จ๐ฐ ๐๐ง๐ ๐๐๐ญ ๐ ๐ฅ๐๐ญ ๐๐๐ ๐๐๐๐ ๐๐ ๐
๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ก๐ข๐ฌ ๐๐ซ๐๐ฆ๐ข๐ฎ๐ฆ ๐๐๐ฉ๐จ๐ซ๐ญ ๐๐จ ๐๐๐๐๐ฌ๐ฌ ๐ ๐ฎ๐ฅ๐ฅ ๐๐ง๐๐จ๐ซ๐ฆ๐๐ญ๐ข๐จ๐ง @ https://www.coherentmarketinsights.com/promo/buynow/175
Regional Insights:
Among regions, Europe is expected to witness robust growth in the global cancer biomarkers market, owing to the increasing prevalence of cancer in the region. For instance, according to the data published in October 2017 in the European Journal of Breast Health, body fluid tests may be used for early detection of new or recurrent breast cancer.
Key Players:
Key players operating in global cancer biomarkers market are Qiagen N.V., Merck & Co., Inc., Abbott Laboratories, Bio-Rad Laboratories, Bard1 Life Sciences Limited, BioMerieux S.A., Thermo Fisher Scientific Inc., and Becton, Dickinson and Company, among others.
๐๐จ ๐๐๐ญ ๐๐๐ฌ๐๐๐ซ๐๐ก ๐๐๐ ๐๐ซ๐จ๐๐ก๐ฎ๐ซ๐ ๐๐๐ซ๐ @ https://www.coherentmarketinsights.com/insight/request-pdf/175
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Overview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Biomarker Type
- Market Snippet, By Cancer Type
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Epidemiology
- Recent Developments
- PEST Analysis
- Reimbursement Scenario
- Market Dynamics
- Global Cancer Biomarkers Market, By Biomarker Type, 2015โ2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016โ2025
- Segment Trends
- Protein Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Genetic Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Other Cancer Biomarkers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Introduction
- Global Cancer Biomarkers Market, By Cancer Type, 2015โ2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016โ2025
- Segment Trends
- Breast Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Lung Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Prostate Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Kidney Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Liver Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Other Cancers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Introduction
- Global Cancer Biomarkers Market, By End User, 2015โ2025, (US$ Million)
- Introduction
- Market Share Analysis, 2016 and 2025 (%)
- Y-o-Y Growth Analysis, 2016โ2025
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Academic and Cancer Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2015โ2025, (US$ Million)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/cancer-biomarkers-market-to-surpass-us-337-billion-by-2025-847
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837